Lexpos News

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/02/2024) announced the following list of price concessions for February 2024. Drug Pack size Price concession Amiloride 5mg tablets 28 £15.59 Amoxicillin 250mg/5ml oral suspension 100 £2.49 Betahistine [...]

The post February 2024 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Community Pharmacy England last week briefed Conservative MPs on the unlocked potential of community pharmacies to help with prevention and tackling the burden of long-term conditions, if the current pressures on the sector can be eased. The event brought together a small group of influential and supportive MPs with community pharmacy owners, our Chief Executive [...]

The post Conservative MPs briefed on prevention role for sector appeared first on Community Pharmacy England.

In a new report, The King’s Fund has called for the health and care system in England to be radically refocused to put primary and community care at its core to make it effective and sustainable. The report authors argue that the failure to grow and invest in primary and community health and care services, [...]

The post Call to put primary and community services at core of health and care system appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials MSN/2024/021 Tier 3 – high impact Date of issue 21st February 2024 Link: Medicines Supply Tool Summary Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid is in very limited supply with a resolution date [...]

The post Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules. MSN/2024/019 Tier 3 – high impact  Date of issue 13th February 2024 There will be intermittent supply of all strengths of lisdexamfetamine (Elvanse®) capsules until April 2024. Supplies of various strengths of Elvanse® will be available at different [...]

The post Medicine Supply Notification: Lisdexamfetamine (Elvanse®) capsules appeared first on Community Pharmacy England.